000			01842 a2200541 4500
005			20250517012137.0
264		0	_c20150629
008			201506s 0 0 eng d
022			_a1939-327X
024	7		_a10.2337/db14-1132 _2doi
040			_aNLM _beng _cNLM
100	1		_aCifarelli, Vincenza
245	0	0	_aMetformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms. _h[electronic resource]
260			_bDiabetes _cMay 2015
300			_a1632-42 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAnimals
650	0	4	_aBody Weight
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aDiet, Diabetic
650	0	4	_aEnergy Intake
650	0	4	_aGlucose Intolerance
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMetformin _xtherapeutic use
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Obese
650	0	4	_aMicroRNAs _xgenetics
650	0	4	_aNeoplasms, Experimental _xdrug therapy
650	0	4	_aPancreatic Neoplasms _xdrug therapy
650	0	4	_aPrediabetic State _xdrug therapy
650	0	4	_aRandom Allocation
650	0	4	_aSirolimus _xtherapeutic use
650	0	4	_aSnail Family Transcription Factors
650	0	4	_aTranscription Factors _xgenetics
650	0	4	_aVimentin _xgenetics
700	1		_aLashinger, Laura M
700	1		_aDevlin, Kaylyn L
700	1		_aDunlap, Sarah M
700	1		_aHuang, Jennifer
700	1		_aKaaks, Rudolf
700	1		_aPollak, Michael N
700	1		_aHursting, Stephen D
773	0		_tDiabetes _gvol. 64 _gno. 5 _gp. 1632-42
856	4	0	_uhttps://doi.org/10.2337/db14-1132 _zAvailable from publisher's website
999			_c24522367 _d24522367